Generex Biotechnology
Holding Companies & Conglomerates · Florida, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
10102 Usa Today Way Ste 200, Miramar, Fl...Phone Number
(416) 364-2551Website
www.generex.comRevenue
<$5 MillionIndustry
ZI Rank: 8
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
3
5
2
5
8
About Generex Biotechnology
Generex Biotechnology is an integrated healthcare holding company with end-to-end solutions for patient centric care from rapid diagnosis through delivery of personalized therapies. Generex is building a new kind of healthcare company that extends beyond traditional models providing support to physicians in an MSO network, and ongoing relationships with patients to improve the patient experience and access to optimal care.Explore more
Generex Biotechnology Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Generex Biotechnology your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Generex Biotechnology recently announced quarterly report
Product Launch: Get notified when Generex Biotechnology launches new products
Generex Biotechnology, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Generex Biotechnology is spiking on competitors!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Generex Biotechnology had a recent Job posting/layoffs
Check if Generex Biotechnology has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Generex Biotechnology
Funding: Get notified immidiatlly once Generex Biotechnology has new funding data
Recommended Actions
Find VP level buyers at Generex Biotechnology
Find 2 more new buyers
Compare Similar Companies to Generex Biotechnology
Compare insights from companies similar to Generex Biotechnology, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Generex Biotechnology
<$5M
11-50
Private
$52.2M
1983
DB
David BrusegardChief Operating Officer, Generex Biotechnology
Company Profile Activity
Activity Insights
Generex Biotechnology is experiencing very low activity levels compared to other companies in the Holding Companies & Conglomerates sector.
What does this means?
Generex Biotechnology is drawing exceptional interest within the Holding Companies & Conglomerates industry, suggesting notable developments or strong market momentum, learn more about Generex Biotechnology.
Generex Biotechnology financials insights
Gather financial insights about Generex Biotechnology, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Debt
$2.2M
2020
Other Financing Round
$50M
Generex Biotechnology Tech Stack
A closer look at the technologies used by Generex Biotechnology
Generex Biotechnology News & Media
Generex Biotechnology Corporation Subsidiary, Olaregen Therapeutix Announces its Malaysian Distribution Partner, Nexgen Medical, has gained approval for the use of Excellagen® Wound Conforming Matrix from The Malaysian Ministry of Health, its country’s equivalent to the U.S. FDA
MIRAMAR, Fla., July 26, 2021 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) subsidiary Olaregen Therapeutix announced in May that the company has executed a Distribution Agreement with Nexgen Medical Sdn Bhd, Inc. (“Nexgen”) to be Generex’s exclusive distributor to import, market and sell the Excellagen line of wound care products in Malaysia pending their Ministry of Health’s approval. We are pleased to announce that Nexgen did, in fact, receive The MalaysiNuGenerex Immuno-Oncology Secures $535 Million Valuation from World-Class Independent Valuation & Appraisal Firm
MIRAMAR, Fla., June 22, 2021 (GLOBE NEWSWIRE) -- NuGenerex Immuno-Oncology (NGIO – www.nugenerexio.com), a subsidiary of Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (“Generex” or the “Company”), an innovative and integrated healthcare holding company with end-to-end solutions for patient centric care today announced that the company has received a $535 million valuation from an internationally recognized, independent valuation and appraisal firm that provides valuation advisGenerex Biotechnology Subsidiary NuGenHealth Contracts with Westside Medicine & Cardiology, Inc. to Provide Remote Patient Monitoring (RPM) Services
MIRAMAR, Fla., May 11, 2021 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (“Generex” or the “Company”), an innovative and integrated healthcare holding company with end-to-end solutions for patient centric care including the development of its innovative “Complete Vaccine™” to fight SARS-CoV-2, announced today that its subsidiary NuGenHealth has signed a contract with Westside Medicine & Cardiology, Inc. (WM&C) to provide connected care solutions for patienGenerex Posts Recording of May 6 Shareholder Conference Call Highlighting its Ii-Key COVID Complete Vaccine™ and its Go-Forward Plans for Revenue Producing Assets
MIRAMAR, Fla., May 10, 2021 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (“Generex” or the “Company”), an innovative and integrated healthcare holding company with end-to-end solutions for patient centric care including the development of its innovative “Complete Vaccine™” to fight SARS-CoV-2, today announced that the company has posted the recording from the May 6, 2021 shareholders conference call on our website at www.generex.com. The written transcript
Read more news
Top Holding Companies & Conglomerates Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Generex Biotechnology
Sign Up For FreeTo access detailed company insights
Generex Biotechnology is an integrated healthcare holding company with end-to-end solutions for patient centric care from rapid diagnosis through delivery of personalized therapies. Generex is building a new kind of healthcare company that extends beyond traditional models providing support to physicians in an MSO network, and ongoing relationships... Read More
